EMA launch enhanced monitoring system for availability of medicines used for treating COVID-19

Under this system, each pharmaceutical company will appoint a single contact point who will report to the EMA and national competent authorities all current & anticipated shortages of medicines used in patients with COVID-19, both for centrally & nationally authorised medicines.


European Medicines Agency